To access this element change to forms mode OFF
Grant Award View - GA207640
Ribosome biogenesis and disease
GA ID:
GA207640
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$1,927,015.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Ribosome biogenesis and disease
Purpose:
Ribosomes are macromolecular machines that synthesise all cellular proteins and their catalytic core, the ribosomal RNAs, are synthesised from hundreds of ribosomal genes in a sub-nuclear body termed the nucleolus. This application continues my work on developing drugs that target the nucleolus for cancer therapies and ribosomopathies and investigate new non-ribosomal functions of the nucleolus that we believe are important for normal cellular development and which are dysregulated in disease.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009504
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Australian National University
Recipient ABN:
52 234 063 906
Grant Recipient Location
Suburb:
Canberra City
Town/City:
Canberra City
Postcode:
2601
State/Territory:
ACT
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT
Postcode:
Country:
AUSTRALIA